Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate.

Author(s): Cattaneo A, Carli P, De Marco A, Sonni L, Bracco G, De Magnis A, Taddei GL

Affiliation(s): Institute of Gynecology and Obstetrics, University of Florence, Italy.

Publication date & source: 1996-02, J Reprod Med., 41(2):99-102.

Publication type: Clinical Trial; Randomized Controlled Trial

OBJECTIVE: To evaluate the possible effects of topical testosterone as maintenance therapy after clobetasol propionate treatment. STUDY DESIGN: Thirty-two patients with biopsy-proven vulvar lichen sclerosus (LS), after 24 weeks of treatment with 0.05% clobetasol propionate cream, were randomly distributed into two groups of 16 each and treated for a further length of time (24 weeks) with testosterone 2% ointment or a cream-based preparation (placebo). The patients were examined before and after treatment for symptoms, gross aspects and histologic features. RESULTS: With clobetasol propionate all patients had a marked improvement (P < .001) in both clinical and histologic parameters. After clobetasol propionate therapy, the 16 testosterone-treated patients had significant worsening of their symptoms (P < .05%) and no evident changes in gross aspects (P = NS). The placebo-treated group had good symptomatic control of their disease, with no significant changes in symptoms or gross aspects (P = NS). CONCLUSION: After the good results obtained with clobetasol propionate, treatment with testosterone appeared to have a negative effect, while a regularly provided emollient cream was useful in symptom control.